$1.9B in: Moderna blueprints $100M facility, plans to double the pipeline after a $474M megaround
Moderna has wrapped its latest megaround with $474 million to invest in a new manufacturing facility and its fast-growing staff as it looks to launch new studies for immuno-oncology and double the number of therapies in the pipeline as early as next summer.
Moderna tipped its hand on this fundraising in a Form D a few days ago. But in an interview with Endpoints News, Moderna CEO Stephane Bancel spelled out where the next big investments will be made. At the top of that to-do list is building a $100 million manufacturing facility, which the Cambridge, MA-based biotech has been scouting a location for.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.